S1427
Product Specifications
UNSPSC Description
S1427 is a tranylcypromine-derived LSD1 inhibitor with the IC50 of 390 nM and Ki of 80 nM. S1427 exhibits desirable hERG channel inhibition and microsomal stability profiles. Inhibition of LSD1 partially reduces the proliferation of cancer cells[1].
Target Antigen
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/s1427.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CCC2(CC1)CCNC2)CN[C@H]3C[C@@H]3C4=C(C(F)=CC(F)=C4)OCC5=CC=CN=C5F
Molecular Weight
474.52
References & Citations
[1]Yasuko Koda, et al. Design and Synthesis of Tranylcypromine-Derived LSD1 Inhibitors with Improved hERG and Microsomal Stability Profiles. ACS Med Chem Lett. 2022 Apr 29;13(5):848-854.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-146380/S1427-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-146380/
Clinical Information
No Development Reported
CAS Number
2447061-40-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7169220 Inquire
Rabbit anti-Escherichia coli O9:H4 (strain HS) RSXE Polyclonal Antibody
Ask
View Details 
